Laurent Pharmaceuticals joins battle against COVID-19
Laurent Pharmaceuticals to initiate
world-first testing of LAU-7b in COVID-19 patients
Committed to developing treatments
for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
 |
 |
 |
Cystic Fibrosis |
Science |
LAU-7B |
Events
Laurent Pharmaceuticals to participate at NACFC 2019, in Nashville TN, October 31st - November 2nd 2019
Laurent Pharmaceuticals to participate at BIO2019, in Philadelphia PA, June 3-6 2019